CAJ | 학술논문

目的探讨与分析肺表面活性物质治疗新生儿呼吸窘迫综合征的临床疗效.方法选择2010年9月~2011年9月来广东省东莞市寮步医院就诊的35例新生儿呼吸窘迫综合征患儿为研究对象,对其予以肺表面活性物质治疗,将治疗结果进行回顾性分析.结果35例新生儿呼吸窘迫综合征患儿经治疗后,显效20例(57.14%),有效13例(37.14%),无效2例(5.71%),总有效率94.29%.患儿治疗后与治疗前相比,其肺功能均明显改善,经比较(P<0.05),差异有统计学意义.结论对新生儿呼吸窘迫综合征予以肺表面活性物质治疗能降低肺泡表面张力,维持肺顺应性,提高临床疗效,降低病死率.
목적탐토여분석폐표면활성물질치료신생인호흡군박종합정적림상료효.방법선택2010년9월~2011년9월래광동성동완시료보의원취진적35례신생인호흡군박종합정환인위연구대상,대기여이폐표면활성물질치료,장치료결과진행회고성분석.결과35례신생인호흡군박종합정환인경치료후,현효20례(57.14%),유효13례(37.14%),무효2례(5.71%),총유효솔94.29%.환인치료후여치료전상비,기폐공능균명현개선,경비교(P<0.05),차이유통계학의의.결론대신생인호흡군박종합정여이폐표면활성물질치료능강저폐포표면장력,유지폐순응성,제고림상료효,강저병사솔.
Objective Discussion and analysis of pulmonary surfactant in treatment of neonatal respiratory distress syndrome. Methods Select from September 2010 to September 2011 in our hospital, 35 cases of neonatal respiratory distress syndrome in children as the research object, the pulmonary surfactant therapy, the treatment results of a retrospective analysis. Results 35 cases of neonatal respiratory distress syndrome in children after treatment, markedly effective in 20 cases (57.14%), effective in 13 cases ( 37.14%), invalid in 2 cases (5.71%), the total efficiency of 94.29%. Children after treatment than before treatment, and their lung function were significantly improved by the comparison (P<0.05), the difference was statistically significant. Conclusion The neonatal respiratory distress syndrome to be pulmonary surfactant therapy can reduce alveolar surface tension, maintain lung compliance, improve clinical curative effect, reduce the mortality rate.